Ipamorelin

Ipamorelin is a synthetic pentapeptide that acts as a selective agonist of the growth hormone secretagogue receptor (GHS-R). It has been studied in laboratory and preclinical settings for its role in growth hormone-related signaling and broader endocrine regulation.

Research Overview

Published and preclinical research involving Ipamorelin has explored areas including:

• Growth hormone secretagogue receptor activity
• Growth hormone signaling pathways
• Endocrine and metabolic signaling
• IGF-1-related research models
• Energy-balance and body-composition research models
• Cellular and tissue-response pathways
• Neuroendocrine signaling

Ipamorelin remains an investigational research compound. Findings from laboratory, cellular, animal, or early-stage research should not be interpreted as demonstrating safety, effectiveness, or therapeutic benefit in humans.